Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Martin van den Bent; AF Carpentier; AA Brandes; M Sanson; MJB Taphoorn; HJJA Bernsen; M Frenay; CC Tijssen; W Grisold; L Sipos; H Haaxma-Reiche; J.M. Kros; Mathilde Kouwenhoven; CJ Vecht; A Allgeier; D Lacombe; T Gorlia

doi:10.1200/JCO.2005.04.6078

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Martin van den Bent
, AF Carpentier
, AA Brandes
, M Sanson
, MJB Taphoorn
, HJJA Bernsen
, M Frenay
, CC Tijssen
, W Grisold
, L Sipos
, H Haaxma-Reiche
, J.M. Kros
, Mathilde Kouwenhoven
, CJ Vecht
, A Allgeier
, D Lacombe
, T Gorlia

Research output: Contribution to journal › Article › Academic › peer-review

685 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2715-2722
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	24
Issue number	18
DOIs	https://doi.org/10.1200/JCO.2005.04.6078
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-24-01
EMC MM-03-44-06

Access to Document

10.1200/JCO.2005.04.6078

http://hdl.handle.net/1765/57623

Cite this

van den Bent, M., Carpentier, AF., Brandes, AA., Sanson, M., Taphoorn, MJB., Bernsen, HJJA., Frenay, M., Tijssen, CC., Grisold, W., Sipos, L., Haaxma-Reiche, H., Kros, J. M., Kouwenhoven, M., Vecht, CJ., Allgeier, A., Lacombe, D., & Gorlia, T. (2006). Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial. Journal of Clinical Oncology, 24(18), 2715-2722. https://doi.org/10.1200/JCO.2005.04.6078

van den Bent, Martin ; Carpentier, AF ; Brandes, AA et al. / Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial. In: Journal of Clinical Oncology. 2006 ; Vol. 24, No. 18. pp. 2715-2722.

@article{27187c051dcc4dc48aee1117ecf793a2,

title = "Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial",

author = "\{van den Bent\}, Martin and AF Carpentier and AA Brandes and M Sanson and MJB Taphoorn and HJJA Bernsen and M Frenay and CC Tijssen and W Grisold and L Sipos and H Haaxma-Reiche and J.M. Kros and Mathilde Kouwenhoven and CJ Vecht and A Allgeier and D Lacombe and T Gorlia",

year = "2006",

doi = "10.1200/JCO.2005.04.6078",

language = "Undefined/Unknown",

volume = "24",

pages = "2715--2722",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "18",

}

van den Bent, M, Carpentier, AF, Brandes, AA, Sanson, M, Taphoorn, MJB, Bernsen, HJJA, Frenay, M, Tijssen, CC, Grisold, W, Sipos, L, Haaxma-Reiche, H, Kros, JM, Kouwenhoven, M, Vecht, CJ, Allgeier, A, Lacombe, D & Gorlia, T 2006, 'Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial', Journal of Clinical Oncology, vol. 24, no. 18, pp. 2715-2722. https://doi.org/10.1200/JCO.2005.04.6078

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial. / van den Bent, Martin; Carpentier, AF; Brandes, AA et al.
In: Journal of Clinical Oncology, Vol. 24, No. 18, 2006, p. 2715-2722.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

AU - van den Bent, Martin

AU - Carpentier, AF

AU - Brandes, AA

AU - Sanson, M

AU - Taphoorn, MJB

AU - Bernsen, HJJA

AU - Frenay, M

AU - Tijssen, CC

AU - Grisold, W

AU - Sipos, L

AU - Haaxma-Reiche, H

AU - Kros, J.M.

AU - Kouwenhoven, Mathilde

AU - Vecht, CJ

AU - Allgeier, A

AU - Lacombe, D

AU - Gorlia, T

PY - 2006

Y1 - 2006

U2 - 10.1200/JCO.2005.04.6078

DO - 10.1200/JCO.2005.04.6078

M3 - Article

C2 - 16782911

SN - 0732-183X

VL - 24

SP - 2715

EP - 2722

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -

van den Bent M, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJB, Bernsen HJJA et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial. Journal of Clinical Oncology. 2006;24(18):2715-2722. doi: 10.1200/JCO.2005.04.6078